Simplex Trading, LLC 89bio, Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,055 shares of ETNB stock, worth $15,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,055

Holding current value

$15,371

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$7.31 - $10.9 $15,022 - $22,399	2,055 New	2,055 $16,000
Q4 2023 Feb 02, 2024	SELL	$6.66 - $16.03 $649,629 - $1.56 Million	-97,542 Reduced 95.0%	5,133 $57,000
Q3 2023 Nov 01, 2023	BUY	$15.06 - $19.41 $1.04 Million - $1.34 Million	68,817 Added 203.25%	102,675 $1.59 Million
Q2 2023 Aug 04, 2023	SELL	$14.15 - $22.03 $1.75 Million - $2.73 Million	-123,842 Reduced 78.53%	33,858 $641,000
Q1 2023 Apr 27, 2023	BUY	$10.48 - $16.94 $922,418 - $1.49 Million	88,017 Added 126.31%	157,700 $2.4 Million
Q4 2022 Feb 02, 2023	BUY	$5.52 - $12.73 $384,650 - $887,064	69,683 New	69,683 $887,000
Q2 2022 Aug 03, 2022	BUY	$2.09 - $4.02 $41,616 - $80,046	19,912 Added 13732.41%	20,057 $64,000
Q1 2022 May 02, 2022	SELL	$3.45 - $14.99 $11,509 - $50,006	-3,336 Reduced 95.83%	145 $0
Q2 2021 Aug 12, 2021	SELL	$17.42 - $28.0 $141,763 - $227,864	-8,138 Reduced 70.04%	3,481 $65,000
Q1 2021 Apr 26, 2021	BUY	$20.22 - $26.73 $234,936 - $310,575	11,619 New	11,619 $275,000

Others Institutions Holding ETNB

# of Institutions

157

Shares Held

107M

Call Options Held

65K

Put Options Held

1.2M

Ra Capital Management, L.P. Boston, MA

14.2M
Shares

$106 Million
1.71% of portfolio
Janus Henderson Group PLC London, X0

13.3M
Shares

$99.3 Million
0.06% of portfolio
Suvretta Capital Management, LLC New York, NY

8.03M
Shares

$60.1 Million
2.69% of portfolio
Bvf Inc San Francisco, CA

7.57M
Shares

$56.6 Million
1.85% of portfolio
Rtw Investments, LP New York, NY

7.38M
Shares

$55.2 Million
0.99% of portfolio

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $348M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account